Zydus Cadila to make an application for Phase-3 trials in December, wishes to launch vaccine by March
The Ahmedabad-based drug maker will submit the results of its phase-2 trials next week, which "will ascertain the safety, dose…
The Ahmedabad-based drug maker will submit the results of its phase-2 trials next week, which "will ascertain the safety, dose…